[SYRS] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
09-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -48.88%
YoY- -56.48%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 2,954 -5,467 3,891 6,276 5,467 7,802 5,697 -35.48%
PBT -23,789 -4,774 -30,253 -34,481 -25,146 -23,813 -26,027 -5.82%
Tax -8,865 -32,349 -9,201 712 -1,507 986 984 -
NP -14,924 27,575 -21,052 -35,193 -23,639 -23,813 -26,027 -31.00%
Tax Rate - - - - - - - -
Total Cost 17,878 -33,042 24,943 41,469 29,106 31,615 31,724 -31.79%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -505.21 -504.39 -541.04 -560.76 -432.39 -305.22 -456.85 6.94%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.54 0.99 -2.24 -5.51 -3.75 -3.78 -4.14 -74.31%
EPS Diluted -0.54 0.99 -2.24 -5.51 -3.75 -3.78 -4.14 -74.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.